| Gene of the month: lymphocyte-activation gene 3 (LAG-3) MP Lythgoe, DSK Liu, NE Annels, J Krell, AE Frampton Journal of clinical pathology 74 (9), 543-547, 2021 | 40 | 2021 |
| The mystery of the thymus gland D Liu, H Ellis Clinical Anatomy 29 (6), 679-684, 2016 | 29 | 2016 |
| “Open Sesame?”: Biomarker status of the human equilibrative nucleoside transporter-1 and molecular mechanisms influencing its expression and activity in the uptake and … O Randazzo, F Papini, G Mantini, A Gregori, B Parrino, DSK Liu, ... Cancers 12 (11), 3206, 2020 | 27 | 2020 |
| Size-exclusion chromatography as a technique for the investigation of novel extracellular vesicles in cancer DSK Liu, FM Upton, E Rees, C Limb, LR Jiao, J Krell, AE Frampton Cancers 12 (11), 3156, 2020 | 27 | 2020 |
| Pharmacogenetics of treatments for pancreatic cancer B El Hassouni, G Li Petri, DSK Liu, S Cascioferro, B Parrino, W Hassan, ... Expert opinion on drug metabolism & toxicology 15 (6), 437-447, 2019 | 26 | 2019 |
| The role of circular rnas in pancreatic ductal adenocarcinoma and biliary-tract cancers C Limb, DSK Liu, MT Veno, E Rees, J Krell, IN Bagwan, E Giovannetti, ... Cancers 12 (11), 3250, 2020 | 25 | 2020 |
| Graphene sensor arrays for rapid and accurate detection of pancreatic cancer exosomes in patients’ blood plasma samples T Yin, L Xu, B Gil, N Merali, MS Sokolikova, DCA Gaboriau, DSK Liu, ... ACS nano 17 (15), 14619-14631, 2023 | 21 | 2023 |
| Quantitative massively parallel proteomics I Peikon, G Tong, D Liu, C Chu US Patent App. 17/074,224, 2021 | 15 | 2021 |
| Cardiomyocytes are protected from antiretroviral nucleoside analog-induced mitochondrial toxicity by overexpression of PGC-1α Y Liu, E Shim, Y Crespo-Mejias, PG Nguyen, A Gibbons, D Liu, E Shide, ... Cardiovascular Toxicology 15, 224-231, 2015 | 14 | 2015 |
| The clinical significance of transfer RNAs present in extracellular vesicles DSK Liu, QZC Yang, M Asim, J Krell, AE Frampton International journal of molecular sciences 23 (7), 3692, 2022 | 9 | 2022 |
| Crizotinib sensitizes the erlotinib resistant HCC827GR5 cell line by influencing lysosomal function N Van Der Steen, K Keller, H Dekker, L Porcelli, RJ Honeywell, ... Journal of cellular physiology 235 (11), 8085-8097, 2020 | 8 | 2020 |
| 543P Neoadjuvant MRx0518 treatment is associated with significant gene and metagene signature changes in solid tumours M Lythgoe, M Adriani, J Stebbing, J Clark, E Pickford, A Frampton, D Liu, ... Annals of Oncology 32, S607, 2021 | 5 | 2021 |
| Bile Microbiome Signatures Associated with Pancreatic Ductal Adenocarcinoma Compared to Benign Disease: A UK Pilot Study N Merali, T Chouari, J Terroire, MD Jessel, DSK Liu, JH Smith, ... International journal of molecular sciences 24 (23), 16888, 2023 | 4 | 2023 |
| Immune modulation and the oral live biotherapeutic product, MRx0518, in treatment-naïve patients with cancer: Updated safety data. M Lythgoe, P Dama, AE Frampton, E Pickford, L Tookman, P Cunnea, ... Journal of clinical oncology 41 (16_suppl), 3145-3145, 2023 | 4 | 2023 |
| Plasma extracellular vesicles contain unannotated small RNA clusters suitable as biomarkers for detecting early hepatocellular carcinoma DSK Liu, AE Frampton Gut 71 (10), 1935-1936, 2022 | 2 | 2022 |
| Neuroendocrine neoplasms: identification of novel metabolic circuits of potential diagnostic utility B Jiménez, MR Abellona U, P Drymousis, M Kyriakides, AK Clift, DSK Liu, ... Cancers 13 (3), 374, 2021 | 2 | 2021 |
| Can circulating tumor and exosomal nucleic acids act as biomarkers for pancreatic ductal adenocarcinoma? DSK Liu, M Mato Prado, E Giovannetti, LR Jiao, J Krell, AE Frampton Expert review of molecular diagnostics 19 (7), 553-558, 2019 | 1 | 2019 |
| Methods for assaying target proteins on extracellular vesicles in plasma C Batenchuk, J Lin, K Kulig, A Lobito, D Liu, W Luk, J Sullivan US Patent App. 18/268,925, 2024 | | 2024 |
| MicroRNAs derived from pre-operative bile shows differential expression in pancreatic ductal adenocarcinoma (PDAC) and cholangiocarcinoma (CCA) D Liu, L Jiao, J Krell, A Frampton European Journal of Surgical Oncology 50 (1), 2024 | | 2024 |
| A bile-based microRNA signature for differentiating malignant from benign pancreaticobiliary disease M Mato Prado, JR Puik, L Castellano, E López-Jiménez, DSK Liu, ... Experimental hematology & oncology 12 (1), 101, 2023 | | 2023 |
Professor Adam E. FramptonHead of Oncology & Assoc. Professor in Surgical Oncology, Section of Oncology, FHMS, Uni. of Surrey在 surrey.ac.uk 的电子邮件经过验证
